Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
21.75
0.02 (0.09%)
At close: Oct 16, 2025, 3:59 PM
21.75
0.00%
After-hours: Oct 16, 2025, 04:10 PM EDT
0.09% (1D)
| Bid | 19.61 |
| Market Cap | 1.29B |
| Revenue (ttm) | 316K |
| Net Income (ttm) | -100.22M |
| EPS (ttm) | -1.99 |
| PE Ratio (ttm) | -10.93 |
| Forward PE | -9.1 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 23 |
| Volume | 423,718 |
| Avg. Volume (20D) | 464,487 |
| Open | 21.55 |
| Previous Close | 21.73 |
| Day's Range | 21.55 - 22.42 |
| 52-Week Range | 13.30 - 30.03 |
| Beta | 1.02 |
| Ex-Dividend Date | n/a |
About ELVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ELVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ELVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+11.44%
Enliven Therapeutics shares are trading higher. Th...
Unlock content with
Pro Subscription
5 months ago
-10.41%
Enliven Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.
